Abstract
In light of the American Diabetes Association's recommendation that fasting glucose alone with the oral glucose tolerance test should be used to diagnose diabetes mellitus, assesses mortality associated with the ADA fasting-glucose criteria compared with the WHO 2 h post-challenge glucose criteria. Finds that fasting-glucose concentrations alone do not identify individuals at increased risk of death associated with hyperglycaemia. The oral glucose tolerance test provides additional prognostic information and enables detection of individuals with impaired glucose tolerance, who have the greatest attributable risk of death. (Original abstract - amended)